So it seems that good reason that price of AMAVF isn't following earnings is that the P/E is shrinking
their 2015 estimated earnings = $2.41 2016 estimated earnings= $3.48 If indeed there turns out to be a 40% growth rate, , the stock deserves a high P/E.
Arcam is still in at's infancy, it could grow in the 30% or better range for many years, in double digits for at least a decade.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.